Disposable Bronchoscope Market By Product (Large, Regular, Slim, Ultra-slim and Extra-large, By Usage (Bedside Procedures, Emergency Rooms, Bronchoscopy Suites and ICUs, By Indication (Lung Cancer, Pulmonary Infections, Interstitial Lung Disease, Tuberculosis, COPD and Cystic Fibrosis, By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

The Global Disposable Bronchoscope Market size is expected to be worth around US$ 969.4 Million by 2034, from US$ 428.1 Million in 2024, growing at a CAGR of 8.5% during the forecast period from 2025 to 2034.

The global disposable bronchoscope market is experiencing significant growth, driven by a shift from traditional open surgeries to minimally invasive procedures for both diagnostic and therapeutic purposes. This transition is fueled by the advantages of minimally invasive techniques, including reduced recovery time, lower risk of complications, and enhanced patient comfort. Additionally, the increasing incidence of lung cancer and the rising demand for local biopsies have amplified the need for advanced diagnostic tools like disposable bronchoscopes.

• According to ACS, in 2023, it was estimated that 1,958,310 new cancer cases were diagnosed, and 609,820 deaths would occur due to cancer in the United States.
• The incidence rate of lung and bronchus cancer was 49.0 cases per 100,000 individuals annually, while the mortality rate stood at 32.4 deaths per 100,000 individuals per year.

The growing geriatric population, which is more susceptible to chronic respiratory disorders such as COPD, pulmonary infections, and interstitial lung disease, further contributes to market expansion. Technological advancements in bronchoscopy devices, including improved imaging capabilities, enhanced flexibility, and ease of use, are also playing a crucial role in driving adoption. These innovations are particularly valuable in critical care settings, such as ICUs and emergency rooms, where precision and efficiency are paramount. As a result, the market is poised for sustained growth.

The rising incidence of chronic respiratory conditions, including lung cancer, tumors, airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive pulmonary disease (COPD), is fueling the demand for bronchoscopies and local biopsies. These procedures are essential for diagnosing and treating airway abnormalities, obtaining lung tissue samples, and evaluating growths in the airways.

For example, NHS Digital reports that approximately 1.17 million people in England were hospitalized with COPD during the 2020-2021 period, accounting for 1.9% of the population. Additionally, the World Health Organization (WHO) states that COPD was the third leading cause of death worldwide in 2019, responsible for 3.23 million deaths. 

Key Takeaways

• The Disposable Bronchoscope market generated a revenue of US$ 428.10 Million in 2024 and is predicted to reach US$ 893.30 Million, with a CAGR of 8.5%.
• Based on the Product, the Regular segment generated the most revenue for the market with a market share of 32.7%.
• Based on the Usage, the Bedside Procedures use segment generated the most revenue for the market with a market share of 34.5%.
• By Indication, the Pulmonary Infections segment contributed the most to the market and secured a market share of 41.8%.
• Region-wise North America remained the lead contributor to the market, by claiming the highest market share, amounting to 38.20%.

Product Analysis

The product segment is further classified into Large, Regular, Slim, Ultra-slim and Extra-large. The regular sub-segment in the product type segment of the Disposable Bronchoscope Market is the dominant category due to its widespread adoption in various medical procedures. Regular disposable bronchoscopes are designed for standard diagnostic and therapeutic applications, offering versatility and reliability across a broad range of use cases. These devices are particularly popular in hospitals and diagnostic centers for procedures like bronchoalveolar lavage, foreign body removal, and biopsy collection.

Their dominance is driven by their cost-effectiveness compared to advance or specialty models, making them a preferred choice for routine procedures. Additionally, the increasing awareness of infection control and the benefits of single-use devices further contribute to the growing demand for regular disposable bronchoscopes. The ease of operation, consistent performance, and compatibility with existing healthcare workflows reinforce their position as the leading product type in this market segment.

Usage Analysis

The emergency rooms segment is also anticipated to see significant growth, fueled by the shift from hospitals to outpatient facilities and ambulatory surgical centers, as well as the increasing adoption of same-day surgeries and minimally invasive procedures. Leading companies like Ambu A/S and Boston Scientific are expanding their portfolios through product innovations and acquisitions. For example, recent developments include pediatric-focused disposable bronchoscopes featuring advanced imaging capabilities.

The Bedside Procedures segment dominates the Disposable Bronchoscope Market due to the growing preference for performing diagnostic and therapeutic procedures at the patient’s bedside, particularly in critical care settings such as ICUs. Bedside bronchoscopies offer advantages in terms of reducing patient transport risks and enabling quicker interventions, which is crucial for patients with respiratory distress.

The increasing use of disposable bronchoscopes in these procedures ensures higher infection control standards, as these devices are used once and discarded. This segment’s growth is driven by the rising demand for minimally invasive, patient-centric care and the convenience of performing procedures outside traditional operating rooms.

Indication Analysis

Pulmonary infections hold a dominant position in the indication segment of the global disposable bronchoscope market due to the increasing prevalence of respiratory diseases, particularly in patients with compromised immune systems and chronic conditions like COPD, asthma, and cystic fibrosis. Disposable bronchoscopes are increasingly favored in managing pulmonary infections as they minimize the risk of cross-contamination compared to reusable devices, aligning with stringent infection control protocols in healthcare facilities.

The rising cases of hospital-acquired infections (HAIs) and the global burden of tuberculosis and pneumonia further drive the adoption of disposable bronchoscopes. Their single-use nature enhances patient safety while eliminating the need for complex and time-consuming sterilization processes. Additionally, advancements in disposable bronchoscope technology, such as improved visualization and maneuverability, support their widespread use in diagnosing and treating pulmonary infections, cementing their dominance in this market segment.

End User Analysis

The hospital segment also captured a significant market share in 2024. Large academic and teaching hospitals lead the adoption of innovative medical technologies, including disposable bronchoscopes, due to their potential to improve patient outcomes, enhance diagnostic precision, and optimize clinical workflows.

For example, an article by Becker’s Hospital Review highlighted that over 3,000 hospitals utilize disposable bronchoscopes supplied by Ambu A/S. Moreover, hospitals frequently collaborate with manufacturers to provide insights into product design, usability, and performance, further supporting the segment’s growth.

Key Market Segments

By Product

• Large
• Regular
• Slim
• Ultra-slim
• Extra-large

By Usage

• Bedside Procedures
• Emergency Rooms
• Bronchoscopy Suites
• ICUs

By Indication

• Lung Cancer
• Pulmonary Infections
• Interstitial Lung Disease
• Tuberculosis
• COPD
• Cystic Fibrosis

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Diagnostic Centers

Drivers

Rising Prevalence of Infertility and Hormonal Disorders

The rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and pulmonary infections, is creating significant opportunities for the disposable bronchoscope market. As the global burden of these conditions increases, there is a growing demand for advanced diagnostic and treatment tools, including bronchoscopes. Disposable bronchoscopes are particularly well-suited for these conditions, as they offer a safer and more hygienic alternative to traditional reusable devices, reducing the risk of cross-contamination and hospital-acquired infections (HAIs).

These devices enable physicians to perform minimally invasive procedures, such as bronchial biopsies and airway assessments, with greater accuracy and less discomfort for patients. Additionally, the growing trend of outpatient and ambulatory care settings, where disposable bronchoscopes are favored for their convenience and cost-effectiveness, further boosts the market. As respiratory diseases continue to rise, the demand for disposable bronchoscopes is expected to increase, driving market growth and innovation in the field.

Restrains

Higher Costs Compared to Reusable Bronchoscopes

The higher cost of disposable bronchoscopes compared to reusable alternatives is a key restraint on market growth. Disposable bronchoscopes are generally more expensive on a per-unit basis due to their single-use nature and the advanced technology required for their production. Healthcare facilities, especially in cost-sensitive regions, may find it difficult to justify the expense, particularly when reusable bronchoscopes can be sterilized and reused multiple times.

This cost disparity can limit the adoption of disposable devices in hospitals and clinics where budget constraints are a significant consideration. Although disposable bronchoscopes offer advantages like reduced risk of infection and enhanced patient safety, the upfront investment required may deter smaller or resource-limited institutions.

Additionally, in regions where healthcare systems are already under financial pressure, the ongoing cost of single-use devices may not be viable, hindering market penetration. This cost barrier is slowing the widespread adoption of disposable bronchoscopes despite their numerous benefits.

Opportunities

Increased Focus on Ambulatory Care Centers

The increasing focus on ambulatory care centers (ACCs) is creating significant opportunities for the disposable bronchoscope market. Ambulatory care centers, which provide outpatient services, are becoming more popular due to their convenience, lower costs, and the growing preference for minimally invasive procedures.

Disposable bronchoscopes are well-suited for use in these settings as they offer several advantages, including ease of use, quick procedure times, and minimal patient discomfort. Since these centers often deal with a higher volume of patients and prioritize efficiency, disposable bronchoscopes are ideal because they eliminate the need for sterilization between uses, reducing turnaround time and enhancing workflow.

Furthermore, ACCs benefit from the safety aspect of disposable devices, which help minimize the risk of cross-contamination and hospital-acquired infections, a significant concern in healthcare. As the demand for outpatient care continues to grow, particularly for diagnostic and minor therapeutic procedures, the disposable bronchoscope market is poised for expansion in these settings.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors can significantly impact the disposable bronchoscope market. Economic downturns or recessions may reduce healthcare spending, limiting the adoption of advanced medical devices like disposable bronchoscopes, especially in price-sensitive regions.

Additionally, geopolitical tensions, trade barriers, or regulatory changes can disrupt the supply chain, affecting the availability and cost of raw materials and finished products. Political instability in key markets may also hinder market growth by restricting access to healthcare infrastructure. On the other hand, economic recovery and political stability in emerging markets can boost demand for advanced diagnostic tools, driving market expansion.

Latest Trends

The latest trends in the disposable bronchoscope market include increasing adoption in outpatient and ambulatory care centers due to the convenience and infection control benefits. Technological advancements are driving innovation, with improved imaging capabilities, enhanced maneuverability, and miniaturized designs for better patient outcomes. There’s also a growing focus on eco-friendly disposable devices to address environmental concerns.

Additionally, the rise of minimally invasive procedures and the emphasis on patient safety are fueling demand. Manufacturers are exploring cost-effective solutions to make disposable bronchoscopes more affordable, while partnerships with healthcare providers are enabling product development and feedback-driven improvements.

Regional Analysis

North America Dominates the Global Disposable Bronchoscope Market

In 2024, North America led the disposable bronchoscope market with a revenue share of 38.20%. This dominance can be attributed to the rapid adoption of advanced technologies, the growing trend of minimally invasive procedures, an aging population, the rising prevalence of chronic respiratory diseases, and robust healthcare infrastructure.

The region also benefits from the presence of key manufacturers, suppliers, distributors, and regulatory approvals for disposable bronchoscopes. The U.S. accounted for 91.1% of the North American market in 2024, driven by the increasing incidence of respiratory conditions such as COPD and lung cancer. According to the CDC, 4.6% of U.S. adults were diagnosed with COPD in 2022, increasing demand for bronchitis treatments and contributing to market growth. Additionally, several companies are launching disposable bronchoscopes in the country, further propelling market expansion.

Canada’s disposable bronchoscope market is expected to grow at the fastest rate from 2024 to 2030, driven by the presence of major market players and the rising incidence of lung cancer. The Canadian Cancer Society’s 2023 report estimates 32,100 new lung cancer cases in 2024, highlighting the increased demand for disposable bronchoscopes.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

The competitive landscape in the disposable bronchoscope market is characterized by the presence of several key players, including Ambu A/S, Olympus Corporation, and Boston Scientific. These companies focus on product innovation, technological advancements, and expanding their market reach through strategic partnerships and collaborations.

Market players are increasingly investing in research and development to improve the quality and functionality of disposable bronchoscopes, such as enhanced imaging and maneuverability features. Additionally, regulatory approvals and robust distribution networks play a critical role in driving market growth. The competitive environment is also shaped by price competitiveness and the growing emphasis on patient safety and infection control.

Top Key Players in the Disposable Bronchoscope Market

• AMBU A/S
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Karl Storz GmbH & Co. KG
• NeoScope Inc.
• Olympus Corporation
• PENTAX Medical
• Karl Storz SE & Co.
• Endoso Life
• Innovex Medical Co., Ltd.
• Hunan Vathin Medical Instrument Co., Ltd.
• Zhejiang Geyi Medical Instrument Co., Ltd.

Recent Developments

• In December 2023: It was announced by Ambu that it had received approval for transitional pass-through (TPT) payment from the Centers for Medicare & Medicaid Services (CMS) for its aScope 5 Broncho HD. Effective from January 2024, this TPT payment, lasting 24 to 36 months, will provide additional reimbursement for outpatient procedures that use this device, potentially enhancing its adoption and utilization in healthcare facilities.
• In April 2023: Verathon, renowned globally in the medical device sector and the creator of GlideScope, introduced their next-generation BFlex2 single-use bronchoscope series. This new series features four different scope sizes and enhanced features aimed at improving the ability of clinicians to treat both adult and pediatric patients across various hospital departments.
• In April 2021: Olympus launched the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes in the U.S., which were developed through collaborations with Hunan Vathin Medical Instrument Co., Ltd. and Veran Medical Technologies, Inc. These high-quality endoscopes are designed to facilitate advanced diagnostic and therapeutic procedures.

Report Scope